|
Dynamic personalized prediction of the individual liver‐related risk after sustained viral response in HCV patients
Clémence Moreau
,
Marine Roux
,
Jérémie Riou
,
Clémence Canivet
,
Etienne Audureau
Article dans une revue
hal-04194684v1
|
|
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response
Jessica Azzi
,
Céline Dorival
,
Carole Cagnot
,
Hélène Fontaine
,
Clovis Lusivika-Nzinga
Article dans une revue
hal-03651922v1
|
|
Performance of Algorithms for Identifying Patients With Chronic Hepatitis B or C Infection in the French Health Insurance Claims Databases Using the ANRS CO22 HEPATHER Cohort
Laurent Lam
,
Hélène Fontaine
,
Nathanael Lapidus
,
Jonathan Bellet
,
Clovis Lusivika‐nzinga
Article dans une revue
hal-03924483v1
|
|
Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort
Tangui Barré
,
Fabrice Carrat
,
Clémence Ramier
,
Hélène Fontaine
,
Vincent Di Beo
Article dans une revue
hal-03784790v1
|
|
Sotrovimab to Prevent Severe COVID-19 in High-Risk Patients Infected with Omicron BA.2
Guillaume Martin-Blondel
,
Anne-Geneviève Marcelin
,
Cathia Soulié
,
Sofia Kaisaridi
,
Clovis Lusivika-Nzinga
Article dans une revue
hal-03777531v1
|
|
Impact of Direct‐Acting Antiviral Treatment for Hepatitis C on Cardiovascular Diseases and Extrahepatic Cancers
Laurent Lam
,
Hélène Fontaine
,
Nathanael Lapidus
,
Céline Dorival
,
Jonathan Bellet
Article dans une revue
hal-03883026v1
|
|
Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S COCOPREV study)
Guillaume Martin-Blondel
,
Anne-Genevieve Marcelin
,
Cathia Soulié
,
Sofia Kaisaridi
,
Clovis Lusivika-Nzinga
Article dans une revue
hal-03784773v1
|
|
Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study
Fabrice Carrat
,
Xavier de Lamballerie
,
Delphine Rahib
,
Hélène Blanché
,
Nathanael Lapidus
Article dans une revue
hal-03600604v1
|
|
Predictive Factors for Hepatocellular Carcinoma in Chronic Hepatitis B Using Structural Equation Modeling: A Prospective Cohort Study
Laurent Lam
,
Hélène Fontaine
,
Marc Bourliere
,
Clovis Lusivika-Nzinga
,
Céline Dorival
Article dans une revue
hal-03224103v1
|
|
Sofosbuvir-Daclatasvir Is Suboptimal in Patients with Genotype 2 Chronic Hepatitis C Infection: Real-life Experience from the HEPATHER ANRS CO22 Cohort
Victor Lédinghen
,
Clovis Lusivika-Nzinga
,
Jean-Pierre Bronowicki
,
Fabien Zoulim
,
Dominique Larrey
Article dans une revue
hal-03704126v1
|
|
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort
Anne Laurain
,
Sophie Metivier
,
Georges Haour
,
Dominique Larrey
,
Céline Dorival
Article dans une revue
hal-02120879v1
|
|
The Dynamic Effect of Direct-acting Antiviral Treatments on the Risk of Hepatocellular Carcinoma in Patients with Cirrhosis and Chronic Hepatitis C
Clovis Lusivika-Nzinga
,
Hélène Fontaine
,
Céline Dorival
,
Mélanie Simony
,
Stanislas Pol
Article dans une revue
hal-03703999v1
|
|
Performance of the marginal structural cox model for estimating individual and joined effects of treatments given in combination
Clovis Lusivika-Nzinga
,
Hana Selinger-Leneman
,
Sophie Grabar
,
Dominique Costagliola
,
Fabrice Carrat
Article dans une revue
inserm-02310904v1
|